Notably, in a previous study, C3ar1 (C3a receptor) deletion rescued tau pathology and attenuated neuroinflammation, synaptic deficits, and neurodegeneration in the PS19 tauopathy mouse model [24]. Here, MAPT is linked to tauopathy.